Mindray Inks Deal to Take Over TDR - Analyst Blog

Mindray Medical International Limited ( MR ), a leading Chinese medical device manufacturer, recently revealed that it has agreed to buy a majority holding in HunanChangsha Tiandiren Biotech Co., Ltd. ("TDR "). The terms of the deal were not revealed as the agreement is not material toMindray's financial results.

TDR is a Chinese producer of microbiology analysis offerings focused on microbial identification, antibiotic susceptibility testing ("ID/AST") as well as blood culture system.TDR , located in Hunan, China, was founded in 1997.

Fast reporting of ID/AST test results and a continuous monitoring blood culture system can yield improved management of antibiotics. The Chinese ID/AST and blood culture system market was valued at $139 million in 2010 and growing at 15% to 20% per annum. The worldwide market was valued at $2.25 billion in 2010 with an annual growth rate of 5%.

Mindray stated microbiology analysis is an important component of In-Vitro Diagnostics (IVD ). The deal demonstratesMindray's determination to grow itsIVD range of products.TDR's offerings will blend into the company's pre-existingIVD offerings.

Mindray is a bellwether in the ChineseMedTech industry with a solid international presence. A key distinction with domestic competitors is that the majority ofMindray's products have CE Mark and/or Food and Drug Administration ("FDA") clearance.

Mindray maintains a decent product pipeline and brings out several new products each year. New products contribute in a major way to its revenues.

The company has entered the premium segment globally, where its competitive advantage is still unclear. Also, on the negative side, health care reform, in China and the U.S., may reduce demand forMindray's products. Competition is fierce and leads to price erosion over time.

Mindray's competitors, in different niche segments, include General Electric ( GE ), Philips ( PHG">PHG ) and Siemens ( SI ). Our Neutral recommendation is supported by a short-termZacks #3 Rank (Hold).

GENL ELECTRIC ( GE ): Free Stock Analysis Report

MINDRAY MEDICAL ( MR ): Free Stock Analysis Report

KONINKLIJKE PHL ( PHG ): Free Stock Analysis Report

SIEMENS AG-ADR ( SI ): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More